內克塔治療 NKTR 深 滬
等待開盤 09-25 09:30:00 美东时间
60.33
+0.730
+1.22%
華盛通- 最 高61.15
- 今 開59.82
- 成交量 187.65万股
- 最 低 57.58
- 昨 收 59.60
- 總市值 7.49亿
- 52周最高 61.15
- 市盈率 靜 --
- 換手率 15.12%
- 52周最低 6.48
- 委 比 -7.99%
- 總股本 1240.69万
- 歷史最高 1670.40
- 量 比 1.35
- 振 幅 5.99%
- 歷史最低 6.189
- 每 手 1
- 風險率 9.69%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 升至450美元，瑞穗上调特斯拉目标价；富国银行上调CoreWeave至"超配"，目标价升至170美元
今日重点评级关注：Guggenheim：维持MBX Biosciences"买入"评级，目标价从44美元升至84美元；Oppenheimer：维持MBX Biosciences"跑赢大市"评级，目标价从38美元升至80美元
09-24 10:23
美股大行评级 | 潜在涨幅302.68%！Maxim Group上调T Stamp目标价至12美元，维持"买入"评级
今日重点评级关注：Maxim Group：维持T Stamp"买入"评级，目标价从8美元升至12美元；Maxim Group：维持Rezolute"买入"评级，目标价从15美元升至20美元
09-22 18:44
BTIG Reiterates Buy on Nektar Therapeutics, Maintains $100 Price Target
BTIG analyst Julian Harrison reiterates Nektar Therapeutics (NASDAQ:NKTR) with a Buy and maintains $100 price target.
09-19 16:22
Why Is Nektar Therapeutics Stock Trading Lower On Thursday?
Nektar reported Phase 2b results showing rezpegaldesleukin improved eczema severity scores and met primary and key secondary endpoints in patients.
09-19 02:31
Nektar Therapeutics Announces New Data From Ongoing REZOLVE-AD Phase 2b Study Of Rezpegaldesleukin At 2025 EADV Congress
Study met primary and key secondary endpoints at week 16 in patients with moderate-to-severe atopic dermatitisHigh dose rezpegaldesleukin achieved statistical significance on multiple patient-reported outcome assessments
09-18 20:47
美股牛股 | 财报大超预期！Ciena科技大涨超23%，美鹰服饰涨近40%
两只绩优股大涨！Ciena科技涨超23%，四季度收入指引为13.2亿美元；美鹰服饰涨近40%，每股收益达0.45美元，大超市场预期>>
09-05 19:03
What's Going On With Nektar Therapeutics Stock On Thursday?
Nektar Therapeutics stock is trading higher with no news, possibly due to Sanofi's disappointing results.
09-05 02:52
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Bone Biologics (NASDAQ:BBLG) stock moved upwards by 38.2% to $2.86 dur...
09-05 01:05
Shoe Carnival, American Eagle, Ciena, Victoria's Secret And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Dow Jones index gaining over 200 points on Th...
09-05 00:56
Cancer Treatment Stocks Surge as $866B Market Attracts Private Investment
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Aug. 14, 2025 /PRNewswire/ -- USA News Group News Commentary – Federal budget cuts have put pressure...
08-15 00:22
